Page last updated: 2024-10-15

2-oxo-3-methylvalerate and Degenerative Diseases, Central Nervous System

2-oxo-3-methylvalerate has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

alpha-keto-beta-methylvaleric acid: RN given refers to parent cpd
3-methyl-2-oxovaleric acid : A 2-oxo monocarboxylic acid that is valeric acid carrying oxo- and methyl substituents at C-2 and C-3, respectively. An alpha-keto acid analogue and metabolite of isoleucine in man, animals and bacteria. Used as a clinical marker for maple syrup urine disease (MSUD).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, HM2
Zhang, H1
Xu, H2
Gibson, GE2
Ou, HC1
Chen, HL1
Fowler, C1

Other Studies

2 other studies available for 2-oxo-3-methylvalerate and Degenerative Diseases, Central Nervous System

ArticleYear
Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation.
    Biochimica et biophysica acta, 2003, Jan-20, Volume: 1637, Issue:1

    Topics: Calcium; Cations, Divalent; Cytochrome c Group; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Humans;

2003
Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death.
    Journal of neuroscience research, 2003, Oct-15, Volume: 74, Issue:2

    Topics: Animals; Caspase 3; Caspases; Cell Death; Cell Membrane Permeability; Chromatin; Cyclosporine; Cytoc

2003
chemdatabank.com